Breast neoplasm

3 papers

Animals3

Trial sponsors

Novartis Pharmaceuticals Corporation
Company11 trialsPhase 43,514 people
Eli Lilly and Company
Company10 trialsPhase 421,709 people
Palleos Healthcare
Company2 trialsPhase 4789 people
Pfizer
Company12 trialsPhase 326,662 people
GSK
Company7 trialsPhase 31,048 people
Sanofi
Company6 trialsPhase 37,294 people
Merck & Co.
Company6 trialsPhase 35,495 people
Roche
Company3 trialsPhase 32,024 people

Latest

1 in 12 months

Radiology13 Oct

Supplemental Breast Cancer Screening with Contrast-enhanced Mammography or Abbreviated MRI for Extremely Dense Breasts: The DENSE-2 Trial

Study protocolBreast cancer

The International Journal of Biochemistry & Cell Biology1 May

Insulin in aging and cancer: antidiabetic drug Diabenol as geroprotector and anticarcinogen

Experiments in miceInterventions

Nutrition and Cancer1 Jan

Retinyl acetate effects on the life span and the incidence of cryptogenic neoplasms in C3H mice

Experiments in miceNeoplasm

The Journal of Pathology1 Oct

Age-specific incidence of neoplasms in untreated NZR/Gd rats: an inbred strain with cardiovascular tumours and liver glycogen storage disease

Experiments in 650 ratsNeoplasm